India, May 30 -- Inflation and retail sales from Germany and private sector credit from the euro area are the top economic news due on Friday. At 2.00 am ET, Destatis is scheduled to issue Germany's ... Read More
India, May 30 -- Regeneron Pharmaceuticals, Inc. (REGN) shares plummeted 19.06 percent to $489.99, down $115.41 on Friday, after announcing mixed results from its Phase 3 trials evaluating itepekimab ... Read More
India, May 30 -- Australia retail sales declined for the first time in four months in April, data from the Australian Bureau of Statistics showed on Friday. Retail sales fell 0.1 percent on a monthly... Read More
India, May 30 -- Regeneron Pharmaceuticals Inc. (REGN) and French drug major Sanofi S.A. (SNYNF,SNY) announced Friday that Itepekimab met the primary endpoint in one of two trials of chronic obstructi... Read More
India, May 30 -- A new small study found that healthy people who regularly smoked marijuana or ate Tetrahydrocannabinol (THC) edibles showed early signs of heart and blood vessel problems, which were ... Read More
India, May 30 -- BioLineRx Ltd. (BLRX) shares surged 45.88 percent to $5.66, up $1.83 on Friday, after announcing that new data from its Phase 2 CheMo4METPANC clinical trial will be presented at the 2... Read More
India, May 30 -- Radical Clean Solutions Ltd., a Nevada-based company headquartered in Long Island, New York, has formally terminated its asset purchase agreement with AgriForce Growing Systems Ltd. (... Read More
India, May 30 -- The Canadian market is exhibiting weakness on Friday, weighed down by losses in energy, healthcare and technology sectors. Amid renewed concerns about a global trade war, the mood in ... Read More
India, May 29 -- The Australian stock market is swinging to modest gains in mid-market moves on Friday after opening in the red, following the broadly positive cues from Wall Street overnight. The ben... Read More
India, May 29 -- Shares of Alzamend Neuro, Inc. (ALZN) are gaining over 82% on Thursday morning after the company announced dosing of first patient in its phase II clinical trial of AL001. ALZN is cu... Read More